La vendita allo scoperto per Pineapple Financial dà agli investitori un'idea del grado in cui gli investitori stanno scommettendo sul declino delle azioni di Pineapple Financial. I dati relativi alle vendite allo scoperto vengono aggiornati ogni due settimane.

Pineapple Financial (AMEX:PAPL) Azioni, Report sulle vendite allo scoperto

Pineapple Financial

Pineapple Financial Inc is a Canada-based mortgage technology and brokerage company that provides mortgage brokerage services and technology solutions to Canadian mortgage agents, brokers, sub-brokers, brokerages, and consumers. Through its data-driven systems together with cloud-based tools, it offers advantages in the Canadian mortgage industry relative to alternative mortgage broker arrangements and also provides back office services.

Pineapple Financial Inc

News

Contracts

CACI

CACI International Awarded $66M Task Order To Provide Expertise To U.S. Navy Naval Surface Warfare Center

Buybacks

AVGO

Broadcom Inc. Announces $10B Share Repurchase Authorization

Guidance

CVRX

CVRx Prelim Q1 Total Revenue Expected To Be ~$12.3M vs $14.67M Est.

Earnings

RSLS

ReShape Lifesciences FY24 EPS $(13.83); Revenue $8.01M Down From $8.68M YoY

LEVI

Levi 2025 Guidance Remains Unchanged Other Than To Reflect Dockers Business As A Discontinued Operation, Does Not Reflect Any Impact From Recently Announced Tariffs

Investors with a lot of money to spend have taken a bullish stance on Tesla (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>).
And retail traders should know.
We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga.
Whether these are institutions or just wealthy individuals, we don't know. But when something this big happens with TSLA, it often means somebody knows something is about to happen.
So how do we know what these investors just did? 
Today, <a href="https://www.benzinga.com/pro/">Benzinga</a>'s options scanner spotted 1000 uncommon options trades for Tesla.
This isn't normal.
The overall sentiment of these big-money traders is split between 46% bullish and 40%, bearish.
Out of all of the special options we uncovered, 463 are puts, for a total amount of $34,596,702, and 537 are calls, for a total amount of $35,191,956.
<h3>Projected Price Targets</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $85.0 to $960.0 for Tesla during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Tesla's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Tesla's substantial trades, within a strike price spectrum from $85.0 to $960.0 over the preceding 30 days.
<h3>Tesla Call and Put Volume: 30-Day Overview</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744056709_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/11/25</td>
<td>$9.05</td>
<td>$9.0</td>
<td>$9.0</td>
<td>$240.00</td>
<td>$450.0K</td>
<td>3.1K</td>
<td>38.8K</td>
</tr>
<tr>
<td>TSLA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/11/25</td>
<td>$13.15</td>
<td>$13.0</td>
<td>$13.15</td>
<td>$230.00</td>
<td>$131.5K</td>
<td>1.1K</td>
<td>43.0K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>04/11/25</td>
<td>$12.95</td>
<td>$12.8</td>
<td>$12.95</td>
<td>$227.50</td>
<td>$125.6K</td>
<td>1.1K</td>
<td>19.7K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>04/11/25</td>
<td>$12.6</td>
<td>$12.5</td>
<td>$12.5</td>
<td>$230.00</td>
<td>$125.0K</td>
<td>5.1K</td>
<td>34.1K</td>
</tr>
<tr>
<td>TSLA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>04/17/25</td>
<td>$36.7</td>
<td>$36.45</td>
<td>$36.45</td>
<td>$260.00</td>
<td>$120.2K</td>
<td>8.5K</td>
<td>2.3K</td>
</tr>
</tbody>
</table>

<h3>About Tesla</h3>
Tesla is a vertically integrated battery electric vehicle automaker and developer of autonomous driving software. The company has multiple vehicles in its fleet, which include luxury and midsize sedans, crossover SUVs, a light truck, and a semi truck. Tesla also plans to begin selling more affordable vehicles, a sports car, and offer a robotaxi service. Global deliveries in 2024 were a little below 1.8 million vehicles. The company sells batteries for stationary storage for residential and commercial properties including utilities and solar panels and solar roofs for energy generation. Tesla also owns a fast-charging network.
After a thorough review of the options trading surrounding Tesla, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Where Is Tesla Standing Right Now?</h3>
<ul>
<li>Currently trading with a volume of 169,593,784, the TSLA's price is down by -3.52%, now at $231.0. </li>
<li>RSI readings suggest the stock is currently is currently neutral between overbought and oversold.</li>
<li>Anticipated earnings release is in 15 days.</li>
</ul>
<h3>What The Experts Say On Tesla</h3>
A total of 5 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $429.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; Consistent in their evaluation, an analyst from Piper Sandler keeps a Overweight rating on Tesla with a target price of $450. 
&#x2A; An analyst from Cantor Fitzgerald has revised its rating downward to Overweight, adjusting the price target to $425. 
&#x2A; An analyst from Wedbush has revised its rating downward to Outperform, adjusting the price target to $550. 
&#x2A; Reflecting concerns, an analyst from Wedbush lowers its rating to Outperform with a new price target of $550. 
&#x2A; An analyst from Guggenheim persists with their Sell rating on Tesla, maintaining a target price of $170. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Tesla with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Options

Markets

TSLA

Spotlight on Tesla: Analyzing the Surge in Options Activity

ROMEOVILLE, Ill., April 07, 2025 (GLOBE NEWSWIRE) -- Solésence, Inc. (OTCQB:<a class="ticker" href="https://www.benzinga.com/stock/NANX#OTCQB">NANX</a>), a leader in scientifically-driven health care solutions across beauty and life science categories, today announced that it has received approval from the Listing Qualifications Department of Nasdaq to transfer its listing to the Nasdaq Capital Market. The Company's securities will be uplisted to Nasdaq at the opening of business on Tuesday, April 8, 2025. Prior to listing on Nasdaq, the Company's shares traded on the OTCQB. Shareholders are not required to take any action as a result of the uplisting.
The Company's shares will now trade under the ticker symbol "SLSN". The approval by Nasdaq was based on the Company meeting all applicable requirements for public listing on the Nasdaq Capital Market.
"We are pleased to announce our uplisting to Nasdaq," said Jess Jankowski, President and Chief Executive Officer of Solésence. "Solésence continues to redefine mineral-based sun protection as beauty brands recognize the novel skin health benefits from our award-winning products. We believe that trading on Nasdaq will increase our visibility within the investment community, broaden our shareholder base, and deliver greater value to our stakeholders. We look forward to this exciting new chapter in our company's history."
"This milestone was achieved through our team's relentless efforts to profitably achieve our mission, our brand partners' collaboration in driving growth at a multiple of the industry's growth rate, and the patience and resilience of our shareholders. We're particularly excited about how Solésence's uplisting to Nasdaq may one day provide resources to enable our company to scale and increase profitability in a manner not available to most of our competitors," said Kevin Cureton, Chief Operating Officer.

NANX

Solésence Announces Uplisting To Nasdaq

Earnings Beats

Earnings Misses

Levi Strauss Q1 2025 Adj. EPS $0.38 Beats $0.28 Estimate, Sales $1.5B Miss $1.541B Estimate

ATHENS, Greece, April 07, 2025 (GLOBE NEWSWIRE) -- Euroseas Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ESEA#NASDAQ">ESEA</a>, the "Company" or "Euroseas"))), an owner and operator of container carrier vessels and provider of seaborne transportation for containerized cargoes, announced today a new time charter contract for its 1,800 teu feeder containership, M/V Monica for a minimum period of 24 to a maximum period of 26 months, at the option of the charterer, at a gross daily rate of $23,500. The new charter period is expected to commence around the end of April to mid-May 2025.
Aristides Pittas, Chairman and CEO of Euroseas commented: "We are very pleased to announce a new time charter contract for our feeder containership, M/V Monica, with a top-tier charterer for 24-26 months at a profitable rate of $23,500. Despite the various macro-economic uncertainties, this fixture highlights the continued strength of the containership charter market, with both periods and rates remaining at very healthy levels, as operators look to secure their requirements in an environment with very limited supply. This charter is expected to generate approximately $12.1 million in EBITDA over the minimum contracted period and increase our charter coverage for 2025 to about 94%, and for 2026 to about 58%, respectively."

ESEA

Euroseas Enters Into 2-year Charter Contract For Its Feeder Containership M/V Monica. Expected To Generate ~$12.1M In EBITA During Contract Period

Outlook for Financial Items in Fiscal 2025
The Company provides its current outlook for certain financial items (which are still under review) for fiscal 2025, which ends on&nbsp;February 3, 2026:
<ul>
<li>Total capital expenditures of&nbsp;less than $220 million2</li>
<li>Pre-opening expense of approximately $20 million</li>
<li>Cash interest expense of $130 million to $140 million &nbsp;</li>
</ul>
_________________________________________ 2 Includes capital expenditures on new stores (net of anticipated payments from landlords), remodels and other initiatives, games and maintenance.

PLAY

Dave & Buster's Sees FY25 Total Capital Expenditures Of Less Than $220M; Pre-Opening Expense Of ~$20M; Cash Interest Expense Of $130M-$140M

Biotech

General

SVRA

Savara Announces Encore Presentations From Phase 3 IMPALA-2 Trial Of Molgramostim Inhalation Solution In Patients With Autoimmune Pulmonary Alveolar Proteinosis At Two Upcoming Scientific Conferences

CORRECTION: Savara Ticker Is "SVRA"

Management

PRAA

PRA Group Names Martin Sjolund As President And CEO, Effective June 17, 2025

Dave &amp; Buster's Enter (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PLAY#NASDAQ">PLAY</a>) reported quarterly earnings of $0.69 per share which missed the analyst consensus estimate of $0.71 by 2.82 percent. This is a 33.01 percent decrease over earnings of $1.03 per share from the same period last year. The company reported quarterly sales of $534.50 million which missed the analyst consensus estimate of $550.37 million by 2.88 percent. This is a 10.78 percent decrease over sales of $599.10 million the same period last year.

Dave & Buster's Enter Q4 Adj $0.69 Misses $0.71 Estimate, Sales $534.50M Miss $550.37M Estimate

Doubleline Capital's Jeffrey Gundlach Says: What We're Seeing Appears To Be Deleveraging in the Bond Market;  Fed Is Really Not In A Position To Reverse Course Or Resume Rate Cuts; Odds Favor A Recession At This Point; "No Way" Tariffs Delay Is Going to Happen, Trump Will Keep This Going

AGMH

AGM Group Holdings Receives Nasdaq Determination Notice; To Be Suspended From Trading On April 10

Wells Fargo analyst Derek Archila maintains Rhythm Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RYTM#NASDAQ">RYTM</a>) with a Overweight and raises the price target from $80 to $91.

Price Target

Analyst Ratings

RYTM

Wells Fargo Maintains Overweight on Rhythm Pharmaceuticals, Raises Price Target to $91

38 analysts have shared their evaluations of Meta Platforms (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) during the recent three months, expressing a mix of bullish and bearish perspectives.
The following table provides a quick overview of their recent ratings, highlighting the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">15</td>
<td align="right">21</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">12</td>
<td align="right">18</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Meta Platforms and provided 12-month price targets. The average target is $754.66, accompanied by a high estimate of $935.00 and a low estimate of $600.00. This upward trend is apparent, with the current average reflecting a 6.79% increase from the previous average price target of $706.66.
<img src="https://www.benzinga.com/files/images/story/2025/1744056067_0.png" alt="price target chart" />
<h2>Diving into Analyst Ratings: An In-Depth Exploration</h2>
A comprehensive examination of how financial experts perceive Meta Platforms is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;------------------------&#x7C;---------------&#x7C;-----------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Brent Thill &#x7C;Jefferies &#x7C;Lowers &#x7C;Buy &#x7C; $600.00&#x7C;$725.00 &#x7C; 
&#x7C;Deepak Mathivanan &#x7C;Cantor Fitzgerald &#x7C;Maintains &#x7C;Overweight &#x7C; $790.00&#x7C;$790.00 &#x7C; 
&#x7C;Brent Thill &#x7C;Jefferies &#x7C;Lowers &#x7C;Buy &#x7C; $725.00&#x7C;$810.00 &#x7C; 
&#x7C;Andrew Boone &#x7C;Citizens Capital Markets&#x7C;Maintains &#x7C;Market Outperform&#x7C; $750.00&#x7C;$750.00 &#x7C; 
&#x7C;Jason Celino &#x7C;Keybanc &#x7C;Lowers &#x7C;Overweight &#x7C; $710.00&#x7C;$750.00 &#x7C; 
&#x7C;Ivan Feinseth &#x7C;Tigress Financial &#x7C;Raises &#x7C;Strong Buy &#x7C; $935.00&#x7C;$645.00 &#x7C; 
&#x7C;Lloyd Walmsley &#x7C;UBS &#x7C;Raises &#x7C;Buy &#x7C; $786.00&#x7C;$736.00 &#x7C; 
&#x7C;Ronald Josey &#x7C;Citigroup &#x7C;Raises &#x7C;Buy &#x7C; $780.00&#x7C;$753.00 &#x7C; 
&#x7C;Jason Helfstein &#x7C;Oppenheimer &#x7C;Raises &#x7C;Outperform &#x7C; $800.00&#x7C;$650.00 &#x7C; 
&#x7C;Justin Post &#x7C;B of A Securities &#x7C;Raises &#x7C;Buy &#x7C; $765.00&#x7C;$710.00 &#x7C; 
&#x7C;Brian Pitz &#x7C;BMO Capital &#x7C;Raises &#x7C;Market Perform &#x7C; $610.00&#x7C;$530.00 &#x7C; 
&#x7C;Gil Luria &#x7C;DA Davidson &#x7C;Raises &#x7C;Buy &#x7C; $800.00&#x7C;$700.00 &#x7C; 
&#x7C;Brad Erickson &#x7C;RBC Capital &#x7C;Raises &#x7C;Outperform &#x7C; $800.00&#x7C;$700.00 &#x7C; 
&#x7C;Eric Sheridan &#x7C;Goldman Sachs &#x7C;Raises &#x7C;Buy &#x7C; $765.00&#x7C;$688.00 &#x7C; 
&#x7C;Mark Zgutowicz &#x7C;Benchmark &#x7C;Maintains &#x7C;Buy &#x7C; $820.00&#x7C;$820.00 &#x7C; 
&#x7C;Deepak Mathivanan &#x7C;Cantor Fitzgerald &#x7C;Raises &#x7C;Overweight &#x7C; $790.00&#x7C;$720.00 &#x7C; 
&#x7C;Youssef Squali &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $770.00&#x7C;$700.00 &#x7C; 
&#x7C;Shyam Patil &#x7C;Susquehanna &#x7C;Raises &#x7C;Positive &#x7C; $800.00&#x7C;$675.00 &#x7C; 
&#x7C;Nat Schindler &#x7C;Scotiabank &#x7C;Raises &#x7C;Sector Perform &#x7C; $627.00&#x7C;$583.00 &#x7C; 
&#x7C;Andrew Boone &#x7C;JMP Securities &#x7C;Maintains &#x7C;Market Outperform&#x7C; $750.00&#x7C;$750.00 &#x7C; 
&#x7C;Josh Beck &#x7C;Raymond James &#x7C;Raises &#x7C;Strong Buy &#x7C; $800.00&#x7C;$725.00 &#x7C; 
&#x7C;Aleksey Yefremov &#x7C;Keybanc &#x7C;Maintains &#x7C;Overweight &#x7C; $750.00&#x7C;$750.00 &#x7C; 
&#x7C;Thomas Champion &#x7C;Piper Sandler &#x7C;Raises &#x7C;Overweight &#x7C; $775.00&#x7C;$670.00 &#x7C; 
&#x7C;Barton Crockett &#x7C;Rosenblatt &#x7C;Raises &#x7C;Buy &#x7C; $846.00&#x7C;$811.00 &#x7C; 
&#x7C;Ross Sandler &#x7C;Barclays &#x7C;Raises &#x7C;Overweight &#x7C; $705.00&#x7C;$630.00 &#x7C; 
&#x7C;Ken Gawrelski &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $752.00&#x7C;$685.00 &#x7C; 
&#x7C;Jeffrey Wlodarczak &#x7C;Pivotal Research &#x7C;Raises &#x7C;Buy &#x7C; $875.00&#x7C;$800.00 &#x7C; 
&#x7C;James Lee &#x7C;Mizuho &#x7C;Raises &#x7C;Outperform &#x7C; $750.00&#x7C;$675.00 &#x7C; 
&#x7C;Colin Sebastian &#x7C;Baird &#x7C;Raises &#x7C;Outperform &#x7C; $750.00&#x7C;$680.00 &#x7C; 
&#x7C;Aleksey Yefremov &#x7C;Keybanc &#x7C;Raises &#x7C;Overweight &#x7C; $750.00&#x7C;$700.00 &#x7C; 
&#x7C;Greg Miller &#x7C;JMP Securities &#x7C;Maintains &#x7C;Market Outperform&#x7C; $750.00&#x7C;$750.00 &#x7C; 
&#x7C;Barton Crockett &#x7C;Rosenblatt &#x7C;Maintains &#x7C;Buy &#x7C; $811.00&#x7C;$811.00 &#x7C; 
&#x7C;Meta Marshall &#x7C;Wedbush &#x7C;Raises &#x7C;Outperform &#x7C; $700.00&#x7C;$680.00 &#x7C; 
&#x7C;Deepak Mathivanan &#x7C;Cantor Fitzgerald &#x7C;Lowers &#x7C;Overweight &#x7C; $720.00&#x7C;$730.00 &#x7C; 
&#x7C;Josh Beck &#x7C;Raymond James &#x7C;Raises &#x7C;Strong Buy &#x7C; $725.00&#x7C;$675.00 &#x7C; 
&#x7C;Brian Nowak &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Overweight &#x7C; $660.00&#x7C;$600.00 &#x7C; 
&#x7C;Ken Gawrelski &#x7C;Wells Fargo &#x7C;Raises &#x7C;Overweight &#x7C; $685.00&#x7C;$641.00 &#x7C; 
&#x7C;Aleksey Yefremov &#x7C;Keybanc &#x7C;Raises &#x7C;Overweight &#x7C; $700.00&#x7C;$655.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Meta Platforms. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Meta Platforms compared to the broader market.</li>
<li>Price Targets: Delving into movements, analysts provide estimates for the future value of Meta Platforms's stock. This analysis reveals shifts in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Meta Platforms's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/META/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Meta Platforms analyst ratings.</a>
<h2>Get to Know Meta Platforms Better</h2>
Meta is the largest social media company in the world, boasting close to 4 billion monthly active users worldwide. The firm's "Family of Apps," its core business, consists of Facebook, Instagram, Messenger, and WhatsApp. End users can leverage these applications for a variety of different purposes, from keeping in touch with friends to following celebrities and running digital businesses for free. Meta packages customer data, gleaned from its application ecosystem and sells ads to digital advertisers. While the firm has been investing heavily in its Reality Labs business, it remains a very small part of Meta's overall sales.
<h3>Financial Milestones: Meta Platforms's Journey</h3>
Market Capitalization Analysis: With a profound presence, the company's market capitalization is above industry averages. This reflects substantial size and strong market recognition.
Revenue Growth: Over the 3M period, Meta Platforms showcased positive performance, achieving a revenue growth rate of 20.63% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. In comparison to its industry peers, the company stands out with a growth rate higher than the average among peers in the Communication Services sector.
Net Margin: Meta Platforms's net margin excels beyond industry benchmarks, reaching 43.07%. This signifies efficient cost management and strong financial health.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 12.0%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Meta Platforms's ROA surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 7.83% ROA, the company effectively utilizes its assets for optimal returns.
Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.27.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Assessing Meta Platforms: Insights From 38 Financial Analysts

Ratings for Ingredion (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INGR#NYSE">INGR</a>) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for Ingredion, presenting an average target of $148.75, a high estimate of $167.00, and a low estimate of $133.00. Observing a downward trend, the current average is 7.75% lower than the prior average price target of $161.25. 
<img src="https://www.benzinga.com/files/images/story/2025/1744056058_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Ingredion among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Cody Ross &#x7C;UBS &#x7C;Lowers &#x7C;Neutral &#x7C; $145.00&#x7C;$165.00 &#x7C; 
&#x7C;Kristen Owen &#x7C;Oppenheimer &#x7C;Lowers &#x7C;Outperform &#x7C; $167.00&#x7C;$178.00 &#x7C; 
&#x7C;Andrew Strelzik &#x7C;BMO Capital &#x7C;Lowers &#x7C;Market Perform &#x7C; $133.00&#x7C;$147.00 &#x7C; 
&#x7C;Ben Bienvenu &#x7C;Stephens &amp; Co. &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $150.00&#x7C;$155.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ingredion. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Delving into assessments, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings communicate expectations for the relative performance of Ingredion compared to the broader market.</li>
<li>Price Targets: Understanding forecasts, analysts offer estimates for Ingredion's future value. Examining the current and prior targets provides insight into analysts' changing expectations.</li>
</ul>
Capture valuable insights into Ingredion's market standing by understanding these analyst evaluations alongside pertinent financial indicators. Stay informed and make strategic decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/INGR/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Ingredion analyst ratings.</a>
<h2>About Ingredion</h2>
Ingredion is an ingredients provider for the food, beverage, brewing, and animal nutrition industries. The company processes corn, tapioca, potatoes, stevia, grains, fruits, gums, and vegetables into value-added ingredients. The company has two main product lines: specialty and core ingredients. Specialty ingredients includes starch-based texturizers, natural alternative sweeteners such as stevia, and plant proteins for alternative dairy and snacks. Core ingredients includes sweeteners, such as high-fructose corn syrup, and commodity starches, such as those used for sustainable packaging.
<h3>A Deep Dive into Ingredion's Financials</h3>
Market Capitalization Analysis: Above industry benchmarks, the company's market capitalization emphasizes a noteworthy size, indicative of a strong market presence.
Negative Revenue Trend: Examining Ingredion's financials over 3M reveals challenges. As of 31 December, 2024, the company experienced a decline of approximately -6.3% in revenue growth, reflecting a decrease in top-line earnings. When compared to others in the Consumer Staples sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: Ingredion's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 5.28% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 2.41%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 1.27%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.53, Ingredion adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Analyst Ratings: Simplified</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Some analysts will also offer forecasts for metrics like growth estimates, earnings, and revenue to provide further guidance on stocks. Investors who use analyst ratings should note that this specialized advice comes from humans and may be subject to error.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

INGR

Forecasting The Future: 4 Analyst Projections For Ingredion

Providing a diverse range of perspectives from bullish to bearish, 9 analysts have published ratings on Lazard (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LAZ#NYSE">LAZ</a>) in the last three months.
Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">7</td>
<td align="right">1</td>
<td align="right">1</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">6</td>
<td align="right">0</td>
<td align="right">1</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Lazard and provided 12-month price targets. The average target is $51.67, accompanied by a high estimate of $63.00 and a low estimate of $33.00. This current average represents a 6.8% decrease from the previous average price target of $55.44. 
<img src="https://www.benzinga.com/files/images/story/2025/1744056049_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
The standing of Lazard among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;-----------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Underweight &#x7C; $33.00&#x7C;$56.00 &#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $56.00&#x7C;$63.00 &#x7C; 
&#x7C;Brennan Hawken &#x7C;UBS &#x7C;Raises &#x7C;Neutral &#x7C; $54.00&#x7C;$50.00 &#x7C; 
&#x7C;Aidan Hall &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Raises &#x7C;Market Perform &#x7C; $57.00&#x7C;$52.00 &#x7C; 
&#x7C;Michael Brown &#x7C;Wells Fargo &#x7C;Raises &#x7C;Equal-Weight &#x7C; $55.00&#x7C;$51.00 &#x7C; 
&#x7C;Ryan Kenny &#x7C;Morgan Stanley &#x7C;Raises &#x7C;Equal-Weight &#x7C; $63.00&#x7C;$60.00 &#x7C; 
&#x7C;Richard Ramsden &#x7C;Goldman Sachs &#x7C;Lowers &#x7C;Sell &#x7C; $44.00&#x7C;$51.00 &#x7C; 
&#x7C;Michael Brown &#x7C;Wells Fargo &#x7C;Lowers &#x7C;Equal-Weight &#x7C; $51.00&#x7C;$59.00 &#x7C; 
&#x7C;Aidan Hall &#x7C;Keefe, Bruyette &amp; Woods&#x7C;Lowers &#x7C;Market Perform &#x7C; $52.00&#x7C;$57.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts respond to changes in market conditions and company performance, frequently updating their recommendations. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Lazard. This information offers a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Unveiling insights, analysts deliver qualitative insights into stock performance, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Lazard compared to the broader market.</li>
<li>Price Targets: Gaining insights, analysts provide estimates for the future value of Lazard's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
To gain a panoramic view of Lazard's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/LAZ/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Lazard analyst ratings.</a>
<h2>Discovering Lazard: A Closer Look</h2>
Lazard Inc has a storied history that can be traced back to 1848. The company's revenue is fairly evenly split between financial advisory, such as acquisition and restructuring advisory, and asset management. The company's asset management business is primarily driven by equities (over 80% of assets under management), has an international focus, and targets institutional clients. By geography, the company earns approximately 60% of revenue in the Americas, 35% in EMEA, and 5% in Asia-Pacific. Lazard has offices across more than 20 countries and over 3,000 employees.
<h3>Unraveling the Financial Story of Lazard</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Positive Revenue Trend: Examining Lazard's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 0.72% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Financials sector.
Net Margin: Lazard's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of 10.2%, the company may face hurdles in effective cost management.
Return on Equity (ROE): The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of 13.35%, the company showcases effective utilization of equity capital.
Return on Assets (ROA): Lazard's financial strength is reflected in its exceptional ROA, which exceeds industry averages. With a remarkable ROA of 1.75%, the company showcases efficient use of assets and strong financial health.
Debt Management: Lazard's debt-to-equity ratio surpasses industry norms, standing at 3.45. This suggests the company carries a substantial amount of debt, posing potential financial challenges.
<h2>How Are Analyst Ratings Determined?</h2>
Experts in banking and financial systems, analysts specialize in reporting for specific stocks or defined sectors. Their comprehensive research involves attending company conference calls and meetings, analyzing financial statements, and engaging with insiders to generate what are known as analyst ratings for stocks. Typically, analysts assess and rate each stock once per quarter.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Forecasting The Future: 9 Analyst Projections For Lazard

Press Releases

Pineapple XChange 2024: A Premier Event for the Real Estate and Mortgage Community to Elevate Industry Connections and Insights

Pineapple Financial Expands Network with Addition of Two New Affiliate Brokerages and Reports Record Growth in Agent Network

IPOs

Pineapple Financial, Inc. Announces Pricing of $1.0 Million Registered Direct Offering

Pineapple Financial Unveils Renewals+ Platform, Improves Customer Retention, Adds New Revenue Streams

Correction: Pineapple Financial, Inc. Announces Pricing of $1.0 Million Registered Direct Offering at $0.60 Per Share

Global Mortgage Lender Market Expected to Grow to $1.8 Trillion In 2028

Pineapple Financial, Inc. Announces Closing of $1.0 Million Registered Direct Offering at $0.60 per share

Pineapple Announces Strategic Partnership with BMO to Expand Homeownership Accessibility in Canada

Pineapple Financial Inc. Reports 7.5% Revenue Growth in 2024, and Accelerates Growth to Start 2025

Pineapple Financial Inc. Reports 34.6% Revenue Growth and 26.8% Reduction in Net Loss for First Quarter of Fiscal 2025

FMCC

NRDS

PAPL

TREE

TSX:BMO

Enact Holdings

Federal Agricultural Mortgage Corporation Common Stock

Federal Agricultural

Better Home & Finance Holding Company - Class A Common Stock

Better Home & Finance

CNFinance Holdings Limited American Depositary Shares, each representing twenty (20) Ordinary Shares

CNFinance Hldgs

Mr. Cooper Gr

Essent Group

Finance of America Companies Inc. Class A Common Stock

Finance of America

Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests

Greystone Housing Impact

Guild Holdings Company Class A Common Stock

Guild Holdings

Income Opportunity Realty Investors, Inc. Common Stock

Income Opportunity Realty

loanDepot

Merchants Bancorp

MGIC Investment

NMI Holdings

Onity Group

PennyMac Financial Services, Inc. Common Stock

PennyMac Financial Servs

Radian Group

Rocket Companies, Inc. Class A Common Stock

Rocket Companies

Security National Financial Corporation - Class A Common Stock

Security National Finl

UWM Holdings Corporation Class A Common Stock

UWM Holdings

Velocity Financial

Walker & Dunlop

Waterstone Financial, Inc. - Common Stock

Waterstone Financial

D. Boral Capital

EF Hutton

Screenshot 2024-05-02 at 6.06.39 PM

Pineapple Financial Q2 Update: Revenues Up 59.04%, New Locations Entered, Company Launches All-In-One Deal Management System To Further Boost Growth

Comments

Pineapple Financial

Vendite allo scoperto

Pineapple Financial (AMEX:PAPL) Azioni, Report sulle vendite allo scoperto

Le persone guardano anche

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO